Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 5Thoracic 3Gynecologic 3Sarcoma 1Head & Neck 1Genitourinary 1Breast 1

Conditions

Sarcoma 25Central Nervous System Neoplasms 18Astrocytoma 15Gliosarcoma 14Glioblastoma 14Ovarian Neoplasms 12Oligodendroglioma 10Neuroectodermal Tumors, Primitive, Peripheral 10Brain Neoplasms 10Osteosarcoma 9Neuroblastoma 9Testicular Neoplasms 8Glioma 8Dendritic Cell Sarcoma, Interdigitating 8Medulloblastoma 7Breast Neoplasms 7Choroid Plexus Neoplasms 6Carcinosarcoma 6Burkitt Lymphoma 6Wilms Tumor 5Testicular Germ Cell Tumor 5Stomach Neoplasms 5Rhabdoid Tumor 5Optic Nerve Glioma 5Neoplasms 5Lymphoma, Non-Hodgkin 5Lymphoma, Large B-Cell, Diffuse 5Kidney Neoplasms 5Head and Neck Neoplasms 5Retinoblastoma 4

Interventions

trifluridine tipiracil drug combination 1trametinib 1regorafenib 1milademetan 1larotrectinib 1futibatinib 1dabrafenib 1brigimadlin 1apixaban 1TAS-116 1Rivaroxaban 1Ramucirumab 1Poly(ADP-ribose) Polymerase Inhibitors 1Nivolumab 1Gemcitabine 1Fluorouracil 1Dalteparin 1Clinical Trials, Phase II as Topic 1Cisplatin 1Carboplatin 1Bevacizumab 14-(2-fluoro-4-((((2-phenylacetyl)amino)thioxomethyl)amino)phenoxy)-7-methoxy-N-methyl-6-quinolinecarboxamide 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Biliary Tract Neoplasms × Carboplatin × Sarcoma × Clear all
NCT04999761 2024-09-25

AB122 Platform Study

Taiho Pharmaceutical Co., Ltd.

Phase 1 Recruiting
917 enrolled
GastrointestinalHead & NeckSarcomaThoracic

Biliary Tract Neoplasms, Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Head and Neck Neoplasms, Neoplasm Metastasis, Stomach Neoplasms, Colorectal Neoplasms, Sarcoma, Alveolar Soft Part

Data powered by HemOnc (CC BY 4.0) Colophon âš¡